EFEXOR XL 75 Milligram Prolonged Release Capsules

Country: Ireland

Bahasa: Inggeris

Sumber: HPRA (Health Products Regulatory Authority)

Bahan aktif:

VENLAFAXINE HYDROCHLORIDE

Boleh didapati daripada:

B & S Healthcare

INN (Nama Antarabangsa):

VENLAFAXINE HYDROCHLORIDE

Dos:

75 Milligram

Borang farmaseutikal:

Prolonged Release Capsules

Jenis preskripsi:

Product subject to prescription which may not be renewed (A)

Status kebenaran:

Authorised

Tarikh kebenaran:

0000-00-00

Risalah maklumat

PACKAGE LEAFLET: INFORMATION FOR THE USER 

EFEXOR
®
 XL 75MG PROLONGED-RELEASE CAPSULES, HARD 
(venlafaxine) 

READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE. 
•  Keep this leaflet. You may need to read it again. 
•  If you have any further questions, ask your doctor or
pharmacist. 
•  This medicine has been prescribed for you. Do not
pass it on to others. It may harm 
them, even if their symptoms are the same as yours. 
•  If any of the side effects gets serious, or if you notice any
side effects not listed in this 
leaflet, please tell your doctor or pharmacist. 

The name of your medicine is Efexor

XL 75mg prolonged-release capsules, hard but it will be 
referred to as Efexor

XL throughout this leaflet. 

IN THIS LEAFLET: 
1.  What Efexor XL is and what it is used for 
2.  Before you take Efexor XL 
3.  How to take Efexor XL 
4.  Possible side effects 
5.  How to store Efexor XL 
6.  Further information 

1.  WHAT EFEXOR XL IS AND WHAT IT IS USED FOR 

Efexor XL is an antidepressant that belongs to a group of medicines
called serotonin and 
norepinephrine reuptake inhibitors (SNRIs). This group
of medicines is used to treat 
depression and other conditions such as anxiety disorders. It is
thought that people who are 
depressed and/or anxious have lower levels of serotonin and
noradrenaline in the brain. It is 
not fully understood how antidepressants work, but they may help by
increasing the levels of 
serotonin and noradrenaline in the brain. 

Efexor XL is a treatment for adults with depression. It is also a
treatment for adults with the 
following anxiety disorders: generalised anxiety disorder,
social anxiety disorder (fear or 
avoidance of social situations) and panic disorder (panic
attacks). Treating depression or 
anxiety disorders properly is important to help you get better.
If it is not treated

Ciri produk

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Efexor XL 75mg Prolonged-Release Capsules, hard
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each capsule contains 84.85mg venlafaxine hydrochloride equivalent to 75mg venlafaxine.
For a full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Prolonged-release capsule, hard
_Product imported from Italy and Spain:_
Opaque peach capsules printed in red with 'W' on the cap and ‘75' on the body
4 CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
Treatment of major depressive episodes.
For prevention of recurrence of major depressive episodes.
Treatment of generalised anxiety disorder.
Treatment of social anxiety disorder.
Treatment of panic disorder, with or without agoraphobia.
4.2 POSOLOGY AND METHOD OF ADMINISTRATION
MAJOR DEPRESSIVE EPISODES
The recommended starting dose for prolonged-release venlafaxine is 75 mg given once daily. Patients not responding
to the initial 75 mg/day dose may benefit from dose increases up to a maximum dose of 375 mg/day. Dosage increases
can be made at intervals of 2 weeks or more. If clinically warranted due to symptom severity, dose increases can be
made at more frequent intervals, but not less than 4 days.
Because of the risk of dose-related adverse effects, dose increments should be made only after a clinical evaluation (see
section 4.4). The lowest effective dose should be maintained.
Patients should be treated for a sufficient period of time, usually several months or longer. Treatment should be
reassessed regularly on a case-by-case basis. Longer-term treatment may also be appropriate for prevention of
recurrence of major depressive episodes (MDE). In most of the cases, the recommended dose in prevention of
recurrence of MDE is the same as the one used during the